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We thank Drs. Karnabatidis and Dr. Siablis for their critical
assessment of our paper1 and wish to address their concerns. We
have reviewed the papers which are referenced in their letter.2,3
While we agree that we would have included them in our discus-
sion, their content would not change our conclusions. Indeed, the
papers support most of our conclusions.
The quantity and quality of debris retrieved from Dr. Karn-
abatidis’ 48 cases are not incongruous with rates of emboli we
detected using ultrasound. Interestingly, Dr. Karnabitidis’ series
had three failures (6.2%) with the use of distal protection while
ours had one failure out of 60 (1.7%) without distal protection. At
least one of their failures was directly due to the use of a distal
protection device, one was tibial embolization in spite of embolic
protection, and one was profunda femoris embolization, whose
relation to distal protection cannot be confirmed or refuted. The
images presented in their letter are interesting yet anecdotal and
fail to provide data needed to make conclusions. Our discussion
agrees with Drs. Karnabatidis and Siablis since we state that cases of
acute thrombus may benefit from distal protection. Indeed, many
more cases in their series and the Embolic Filter Protection in
Preventing Lower Extremity Distal Embolization (PROTECT).
Trial registry are acute or subacute where embolization would be
expected to be more likely, as we suggested. We will be presenting
an updated series of 100 cases at the Society for Vascular Surgery in
June 2008 and will report no new cases of embolization, bringing
our rate to 1%.
The studies referenced above had no control group treated
without protection and therefore recommendations for the use of
distal protection cannot be made.2,3 While debris removed from a
filter may cause amazement and disgust, that alone is an insufficient
basis for clinical recommendations. Protection devices may result
in vasospasm and are not 100% effective in preventing adverse
events. The devices are expensive and, while financial issues should
never prevent proper use of technology, they should be considered
when no clear clinical benefit exists.
We are interested in the PROTECT registry but results thus
far include only 28 patients without controls. In addition, these
data have not been subjected to peer review. Mere recognition of
the potential effect of emboli is no substitute for evidence that
these particles cause enough clinical events to merit the use of
protection.
We agree that large controlled studies could answer this
question. We performed our study at our own expense without
industry sponsorship. Our concern is that registries and uncon-
trolled series of 50 patients encourage clinicians to use distal
protection when its benefit remains unproven. If makers of protec-
tion devices wish to determine the benefit of their technology, they
should sponsor controlled studies to answer the question. We are
pursuing such a study in an attempt to better understand the
phenomenon of embolization and its sequelae. While we believe
that protection devices may be a valuable tool in peripheral inter-
ventions, we stand by our original conclusion that currently avail-
able data do not support their routine use.
Nicholas J. Morrissey, MD
The New York Presbyterian Hospital
New York, NY
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